A $200 million public-private fund in New York, intended to support cannabis dispensaries run by those impacted by the war on drugs, is facing scrutiny after an investigation revealed a lopsided deal favoring the private equity firm Chicago Atlantic. The investigation raises concerns about the state’s social equity goals, with critics deeming the deal detrimental to the state and prospective dispensary owners.